iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 113.84 billion as of April 1, 2025. Its market cap has decreased by -49.86% in one year.

Market Cap

113.84B

Enterprise Value

65.31B

Revenue

6.42B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,560.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 113.84B, an increase of 19.46%. That is a compound annual growth rate of 1.26%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	113.84B	-37.98%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	915.06B	97.15%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,537.79B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings